✦ LIBER ✦

Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs

✍ Scribed by Masayoshi Harigai,Akito Takamura,Tatsuya Atsumi,Makoto Dohi…

Book ID: 126348656
Publisher: Springer
Year: 2012
Tongue: English
Weight: 596 KB
Volume: 23
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-012-0657-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and Risk Factors for Serious I

Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

✍ KOMANO, Y.; TANAKA, M.; NANKI, T.; KOIKE, R.; SAKAI, R.; KAMEDA, H.; NAKAJIMA, A 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 337 KB

The risk of serious infection in patient

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

✍ Sakai, Ryoko; Cho, Soo-Kyung; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Y 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 250 KB